Literature DB >> 35355887

Improving Clearance for Renal Replacement Therapy.

Seolhyun Lee1,2, Tammy L Sirich1,2, Timothy W Meyer1,2.   

Abstract

The adequacy of hemodialysis is now assessed by measuring the removal of a single solute, urea. The urea clearance provided by current dialysis methods is a large fraction of the blood flow through the dialyzer, and, therefore, cannot be increased much further. However, other solutes, which are less effectively cleared than urea, may contribute more to the residual uremic illness suffered by patients on hemodialysis. Here, we review a variety of methods that could be used to increase the clearance of such nonurea solutes. New clinical studies will be required to test the extent to which increasing solute clearances improves patients' health.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 35355887      PMCID: PMC8786098          DOI: 10.34067/kid.0002922021

Source DB:  PubMed          Journal:  Kidney360        ISSN: 2641-7650


  83 in total

1.  Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.

Authors:  Tammy L Sirich; Kara Fong; Brett Larive; Gerald J Beck; Glenn M Chertow; Nathan W Levin; Alan S Kliger; Natalie S Plummer; Timothy W Meyer
Journal:  Kidney Int       Date:  2017-01-12       Impact factor: 10.612

2.  Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate.

Authors:  Timothy W Meyer; John W T Peattie; Jared D Miller; Diana C Dinh; Natalie S Recht; Jason L Walther; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2007-01-24       Impact factor: 10.121

3.  Coagulation and fractionated plasma separation and adsorption.

Authors:  B K I Meijers; M F Hoylaerts; P Evenepoel
Journal:  Am J Transplant       Date:  2009-01       Impact factor: 8.086

Review 4.  Use of extracorporeal treatments in the management of poisonings.

Authors:  Marc Ghannoum; Robert S Hoffman; Sophie Gosselin; Thomas D Nolin; Valery Lavergne; Darren M Roberts
Journal:  Kidney Int       Date:  2018-06-27       Impact factor: 10.612

5.  The role of EUTox in uremic toxin research.

Authors:  Raymond Vanholder; Omar Abou-Deif; Angel Argiles; Ulrich Baurmeister; Joachim Beige; Peter Brouckaert; Philippe Brunet; Gerald Cohen; Peter Paul De Deyn; Tilman B Drüeke; Danilo Fliser; Griet Glorieux; Stefan Herget-Rosenthal; Walter H Hörl; Joachim Jankowski; Achim Jörres; Ziad A Massy; Harald Mischak; Alessandra F Perna; Juan Mariano Rodriguez-Portillo; Goce Spasovski; Bernd G Stegmayr; Peter Stenvinkel; Paul J Thornalley; Christoph Wanner; Andrzej Wiecek
Journal:  Semin Dial       Date:  2009 Jul-Aug       Impact factor: 3.455

Review 6.  Review of protein-bound toxins, possibility for blood purification therapy.

Authors:  N Neirynck; G Glorieux; E Schepers; A Pletinck; A Dhondt; R Vanholder
Journal:  Blood Purif       Date:  2013-02-25       Impact factor: 2.614

7.  Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study.

Authors:  Timothy W Meyer; Tammy L Sirich; Kara D Fong; Natalie S Plummer; Tariq Shafi; Seungyoung Hwang; Tanushree Banerjee; Yunnuo Zhu; Neil R Powe; Xin Hai; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2016-03-29       Impact factor: 10.121

8.  Quantifying the Effect of Plasma Viscosity on In Vivo Dialyzer Performance.

Authors:  Daniel Schneditz; John T Daugirdas
Journal:  ASAIO J       Date:  2020-07       Impact factor: 2.872

Review 9.  An overview of renal metabolomics.

Authors:  Sahir Kalim; Eugene P Rhee
Journal:  Kidney Int       Date:  2016-09-28       Impact factor: 10.612

10.  Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.

Authors:  Peter J Blankestijn; Kathrin I Fischer; Claudia Barth; Krister Cromm; Bernard Canaud; Andrew Davenport; Diederick E Grobbee; Jörgen Hegbrant; Kit C Roes; Matthias Rose; Giovanni Fm Strippoli; Robin Wm Vernooij; Mark Woodward; G Ardine de Wit; Michiel L Bots
Journal:  BMJ Open       Date:  2020-02-05       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.